JAK 2 MUTATION DETECTION QUALITATIVE PCR Test
Test Name: JAK 2 MUTATION DETECTION QUALITATIVE PCR Test
Components: 3 mL (2 mL min.) whole blood from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Price: 1240.0 AED
Report Delivery: Sample Mon / Thu by 11 am; Report Wed / Sat
Method: Real Time PCR
Test Type: Cancer
Doctor: Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details
The JAK2 mutation detection qualitative PCR test is a laboratory test used to detect mutations in the JAK2 gene. This gene encodes a protein that plays a role in regulating the production and function of blood cells.
Mutations in the JAK2 gene, specifically the V617F mutation, have been associated with certain blood disorders, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. These disorders involve the overproduction of blood cells, leading to various symptoms and complications.
The qualitative PCR test is designed to identify the presence or absence of the JAK2 V617F mutation in a patient’s DNA sample. It involves amplifying a specific region of the JAK2 gene using polymerase chain reaction (PCR) technology and then analyzing the amplified DNA for the presence of the mutation.
If the JAK2 V617F mutation is detected in a patient’s DNA sample, it indicates that they have a higher risk of developing one of the associated blood disorders. This information can help guide further diagnostic and treatment decisions.
It is important to note that this test is a qualitative test, meaning it only provides a “yes” or “no” answer regarding the presence of the mutation. It does not provide information about the quantity or severity of the mutation.
The JAK2 mutation detection qualitative PCR test is typically performed in specialized laboratories and requires a blood or bone marrow sample from the patient. The results of the test are usually interpreted by a healthcare professional, such as a hematologist or oncologist, who can provide further guidance based on the findings.
| Test Name | JAK 2 MUTATION DETECTION QUALITATIVE PCR Test |
|---|---|
| Components | |
| Price | 1240.0 AED |
| Sample Condition | 3 mL (2 mL min.) whole blood from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Report Delivery | Sample Mon / Thu by 11 am; Report Wed / Sat |
| Method | Real Time PCR |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Test Details | The JAK2 mutation detection qualitative PCR test is a laboratory test used to detect mutations in the JAK2 gene. This gene encodes a protein that plays a role in regulating the production and function of blood cells. Mutations in the JAK2 gene, specifically the V617F mutation, have been associated with certain blood disorders, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. These disorders involve the overproduction of blood cells, leading to various symptoms and complications. The qualitative PCR test is designed to identify the presence or absence of the JAK2 V617F mutation in a patient’s DNA sample. It involves amplifying a specific region of the JAK2 gene using polymerase chain reaction (PCR) technology and then analyzing the amplified DNA for the presence of the mutation. If the JAK2 V617F mutation is detected in a patient’s DNA sample, it indicates that they have a higher risk of developing one of the associated blood disorders. This information can help guide further diagnostic and treatment decisions. It is important to note that this test is a qualitative test, meaning it only provides a “yes” or “no” answer regarding the presence of the mutation. It does not provide information about the quantity or severity of the mutation. The JAK2 mutation detection qualitative PCR test is typically performed in specialized laboratories and requires a blood or bone marrow sample from the patient. The results of the test are usually interpreted by a healthcare professional, such as a hematologist or oncologist, who can provide further guidance based on the findings. |
